Back

Comparative efficacy and safety of nebivolol in hypertension: a systematic review and network meta-analysis

28 August 2026 (09:15 - 09:40)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy for hypertension Beta-Blockers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Duraid Rammahy

Mesopotamia, Oakville (Canada)

3 More presentations in this session

Presentation thumbnail
Risk of incident gout and major adverse cardiovascular events according to angiotensin receptor blocker type in amlodipine-based combination therapy: a nationwide cohort study
Assistant Professor S. Bae (Yongin, KR)
Abstract Slides
Presentation thumbnail
Efficacy and safety of zilebesiran for inadequately controlled hypertension: a systematic review and meta-analysis
Mr T. Bonafe (Varzea Grande, BR)
Abstract Slides
Presentation thumbnail
Female-biased renin release in response to relaxin in isolated rat renal cortex: potential implications for RAAS-mediated congestion with relaxin analogues
Professor M. Ufnal (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Contemporary pharmacotherapy for hypertension

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of bisoprolol compared to other selective beta-1 blockers in the treatment of hypertension: a systematic review and meta-analysis of randomized parallel clinical trials
27 August 2021
thumbnail
Congress Presentation
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
4 April 2025
thumbnail
Congress Presentation
Finerenone in the treatment of cardiac failure in patients with hypertrophic cardiomyopathy
31 August 2025
thumbnail
Congress Presentation
Research network in Africa (RNA) : antihypertensive drugs strategies in 12 African countries
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources